rs2536082

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016203.4(PRKAG2):​c.467-19206T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.925 in 152,260 control chromosomes in the GnomAD database, including 65,263 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.92 ( 65263 hom., cov: 32)

Consequence

PRKAG2
NM_016203.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.787

Publications

3 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016203.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
NM_016203.4
MANE Select
c.467-19206T>C
intron
N/ANP_057287.2
PRKAG2
NM_001407021.1
c.467-19206T>C
intron
N/ANP_001393950.1
PRKAG2
NM_001407022.1
c.467-19206T>C
intron
N/ANP_001393951.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
ENST00000287878.9
TSL:1 MANE Select
c.467-19206T>C
intron
N/AENSP00000287878.3
PRKAG2
ENST00000392801.6
TSL:1
c.335-19206T>C
intron
N/AENSP00000376549.2
PRKAG2
ENST00000488258.5
TSL:1
n.467-19206T>C
intron
N/AENSP00000420783.1

Frequencies

GnomAD3 genomes
AF:
0.924
AC:
140652
AN:
152142
Hom.:
65199
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.982
Gnomad AMI
AF:
0.884
Gnomad AMR
AF:
0.950
Gnomad ASJ
AF:
0.873
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.940
Gnomad FIN
AF:
0.844
Gnomad MID
AF:
0.956
Gnomad NFE
AF:
0.892
Gnomad OTH
AF:
0.936
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.925
AC:
140775
AN:
152260
Hom.:
65263
Cov.:
32
AF XY:
0.924
AC XY:
68762
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.982
AC:
40791
AN:
41546
American (AMR)
AF:
0.950
AC:
14542
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.873
AC:
3030
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5162
AN:
5168
South Asian (SAS)
AF:
0.940
AC:
4535
AN:
4824
European-Finnish (FIN)
AF:
0.844
AC:
8946
AN:
10602
Middle Eastern (MID)
AF:
0.959
AC:
282
AN:
294
European-Non Finnish (NFE)
AF:
0.892
AC:
60698
AN:
68022
Other (OTH)
AF:
0.937
AC:
1983
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
551
1102
1652
2203
2754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.911
Hom.:
41668
Bravo
AF:
0.935
Asia WGS
AF:
0.979
AC:
3402
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.49
DANN
Benign
0.42
PhyloP100
-0.79
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2536082; hg19: chr7-151391929; API